Last reviewed · How we verify

NCT06101368

Effect of Physical Activity on Neurogenesis in Peripheral Diabetic Neuropathy Type-II Diabetes

Status unknown NA Last updated 26 October 2023
What this trial tests

NA trial testing Phsical Activity in Type II Diabetes Mellitus With Neurological Manifestations in 44 participants. Status unknown.

Timeline
1 January 2024
Primary endpoint
31 December 2024
31 March 2025

Quick facts

Lead sponsorHealth Education Research Foundation (HERF)
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment44
Start date1 January 2024
Primary completion31 December 2024
Estimated completion31 March 2025

Drugs / interventions tested

Conditions studied

Sponsor

Health Education Research Foundation (HERF)

Who can join

Adults 45 to 60, any sex, with Type II Diabetes Mellitus With Neurological Manifestations. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Approximately 425 million people worldwide suffer from diabetes, making it a global epidemic. Diabetes consumes 12% of the global health budget, addressing the disease and its complications. In Pakistan, the estimated prevalence of diabetes stands at 9.8%, affecting both males and females. Diabetic peripheral neuropathy is a common complaint that significantly impacts patients' quality of life. Neuropathy is prevalent in 40-55% of diabetes cases, and its incidence rises with age. Additionally, exercise can promote neurogenesis and the release of beneficial factors like BDNF, contributing to improved cognitive function and mood. Aerobic exercises are recommended for managing type 2 diabetes, while resistance training can improve glycemic control and muscle health. Further research is needed to understand the effects of physical activity on neurogenesis in diabetic peripheral neuropathy patients and gender-specific influences on glucose metabolism. The study aims to enhance peripheral neurogenesis, glycemic control, and sensory functions, ultimately improving the overall quality of life for patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Health Education Research Foundation (HERF) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06101368.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing